| Variation | | Type (Consequence) | Condition | Classification, Review status |
---|
| | | Single nucleotide variant (synonymous variant +1 more) | not provided | |
| | | Single nucleotide variant (synonymous variant) | not specified +1 more | |
| | | Single nucleotide variant (missense variant) | not provided | |
| | | Single nucleotide variant (missense variant) | not specified +1 more | GConflicting classifications of pathogenicity |
| | | Deletion | not provided | |
| | | Duplication | not provided | |
| | | Deletion | not provided | |
| | | Duplication | Polyglandular autoimmune syndrome, type 1 | |
| | | Deletion | Progressive myoclonic epilepsy +1 more | GConflicting classifications of pathogenicity |
| | | Deletion | HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED | |
| | | Duplication | not provided | |
| | | Duplication | Developmental and epileptic encephalopathy, 30 +2 more | |
| | CFAP410, KRTAP10-1 +21 more | Duplication | not provided | |
| | CFAP410, KRTAP10-1 +19 more | Duplication | not provided | |
| | | Duplication | not provided | |
| | KRTAP10-2, KRTAP10-3 +47 more | Duplication | not provided | |
| | | Duplication | not provided | |
| | | Duplication | Polyglandular autoimmune syndrome, type 1 | |
Click to view in NCBI Gene